From: The efficacy of the novel zinc-containing desensitizer CAREDYNE Shield on dentin hypersensitivity: a study protocol for a pilot randomized controlled trial
Enrollment
Post allocation
Time point
0
4 weeks (range 3–5 weeks)
Enrollment:
Eligibility screen
X
Informed consent
Allocation
Intervention:
CAREDYNE Shield
Nanoseal
Clinical assessment:
Air blow
Inspection
Palpation